JESSICA SEWARD: Open Payments
NPI 1194123653 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 9 payments from 8 companies in 2025. Trend: 2023 $203 · 2024 $477 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 1 | $162 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: FFRct, LEQVIO, AMVUTTRA, Kerendia, OPSUMIT, LifeVest, REPATHA, VYNDAQEL.
Industry payments across CA — which companies pay providers there.
